Fragile X syndrome carrier screening accompanied by genetic consultation has clinical utility in populations beyond those recommended by guidelines.
Katherine Johansen TaberJeraldine Lim-HarashimaHarris NaemiJim GoldbergPublished in: Molecular genetics & genomic medicine (2019)
These results support the expansion of FXS screening criteria in guidelines.